Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-05-28
Summary
The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Carbamazepine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
James Cornish, M.D. · University of Pennsylvania
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 21 Years
- Max Age
- 51 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-01-31
- Primary Completion
- 1994-02-28
- Completion
- 1994-02-28
Countries
- United States
Study Locations
More Related Trials
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Carvedilol for Psychostimulant Dependence
NCT01171183 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Withdrawal and Pharmacotherapy Response
NCT00566969 ·Status: COMPLETED ·Phase: NA
-
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1
NCT00249691 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
NCT01651364 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
NCT01468012 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral Effects of Drugs: Inpatient (35)
NCT03519022 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clavulanic Acid for the Treatment of Cocaine Use Disorder
NCT05562349 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Modafinil for the Treatment of Cocaine Dependence - 1
NCT00100100 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000301 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence
NCT00344565 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Trial of Nepicastat for Cocaine Dependence
NCT01704196 ·Status: COMPLETED ·Phase: PHASE2
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
NCT00000189 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
NCT00015223 ·Status: COMPLETED ·Phase: PHASE2
-
Rivastigmine as a Treatment for Methamphetamine Dependence
NCT01073319 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacological Modulation of Cocaine Effects - 1
NCT00000201 ·Status: COMPLETED ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2